Settlement Gives Celltrion Date For US Higher-Strength Humira Biosimilar
Plans Q3 2023 Launch For Yuflyma 100mg/ml Citrate-Free Version Of Adalimumab
Celltrion has joined a number of other Humira biosimilar sponsors waiting for launch in 2023 • Source: Roman Samborskyi / Alamy Stock Photo 
